Not available outside of the UK & Ireland.
Application
Bisindolylmaleimide II (BIS II) has been used:as a protein kinase C (PKC) inhibitor to study its effects on cardiomyocyte phenotypesas a PKC inhibitor along with methanandamide (mAEA) to study its effects on murine gastric vagal afferent(GVA) mechanosensitivityas a PKC/protein kinase A (PKA) inhibitor to study its effects on bone-marrow cells
Biochem/physiol Actions
Bisindolylmaleimide II (BIS II) acts as a dual protein kinase A/C (PKA/C) inhibitor.
This product has met the following criteria: